middle.news
Imagion Biosystems Secures $3.75m to Kickstart HER2 Breast Cancer Trial
9:28am on Thursday 25th of June, 2026 AEST
•
Healthcare
Read Story
Imagion Biosystems Secures $3.75m to Kickstart HER2 Breast Cancer Trial
9:28am on Thursday 25th of June, 2026 AEST
Key Points
Raised $3.75m via two-tranche placement at $0.012 per share
Placement includes free attaching listed options exercisable at $0.04
First tranche settled using existing placement capacity, second tranche subject to shareholder approval
Funds to support Phase 1b/2 HER2 breast cancer trial initiation and drug manufacturing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imagion Biosystems (ASX:IBX)
OPEN ARTICLE